Trial Profile
A randomised placebo controlled crossover trial to evaluate the effects of different doses of taurocholic acid in an enema formulation on gastrointestinal hormone secretion and appetite in healthy humans for the future design of treatments for Type 2 diabetes mellitus and obesity
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Jun 2016
Price :
$35
*
At a glance
- Drugs Taurocholic acid (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 03 Apr 2014 Status changed from not yet recruiting to completed as reported by Australian New Zealand Clinical Trials Registry record.
- 26 Jan 2011 New trial record